company background image
CC logo

Chemours NYSE:CC Stock Report

Last Price

US$14.40

Market Cap

US$2.2b

7D

2.0%

1Y

-46.9%

Updated

16 Mar, 2025

Data

Company Financials +

The Chemours Company

NYSE:CC Stock Report

Market Cap: US$2.2b

CC Stock Overview

Provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. More details

CC fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance2/6
Financial Health1/6
Dividends4/6

Rewards

Trading at 32.1% below our estimate of its fair value

Earnings are forecast to grow 45.15% per year

Became profitable this year

Analysts in good agreement that stock price will rise by 54.2%

Risk Analysis

Interest payments are not well covered by earnings

Dividend of 6.94% is not well covered by earnings or free cash flows

High level of non-cash earnings


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

CC logo
Chemours
WA
WaneInvestmentHouse
Community Contributor

Chemours projects $825M-$975M adjusted EBITDA for 2025 with focus on cost savings

The Chemours Company ( CC ), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2024. Key Fourth Quarter 2024 Results & Highlights Net Sales of $1.4 billion, in line with the corresponding prior-year quarter, with TSS achieving record fourth quarter Net Sales, driven by year-over-year growth of 23% in Opteon™ Refrigerants Net Loss attributable to Chemours of $8 million, or $0.05 per diluted share, compared with a Net Loss attributable to Chemours of $18 million, or $0.12 per diluted share, in the corresponding prior-year quarter Adjusted Net Income1 of $16 million, or $0.11 per diluted share, compared with $46 million, or $0.31 per diluted share, in the corresponding prior-year quarter Adjusted EBITDA1,2 of $179 million compared to $176 million in the corresponding prior-year quarter Cash returned to shareholders through dividends of $36 million in the quarter Key Full Year 2024 Results & Highlights Net Sales of $5.8 billion compared to $6.1 billion in the prior year Net Income attributable to Chemours of $86 million, or $0.57 per diluted share, compared with a Net Loss attributable to Chemours of $238 million, or $1.60 per diluted share, in the prior year3 Adjusted Net Income1 of $182 million, or $1.21 per diluted share, compared to $425 million, or $2.82 per diluted share, in the prior year3 Adjusted EBITDA1,2 of $786 million compared to $1.0 billion in the prior year Cash returned to shareholders through dividends of $148 million in the year Established new executive leadership team and announced Chemours’ Pathway to Thrive strategy to drive shareholder value Announced PCC Group’s plans to build a chlor-alkali facility at Chemours’ TiO2 plant in DeLisle, Mississippi and completed our planned Opteon™ YF expansion at Corpus Christi, Texas Fully remediated all four material weaknesses in internal control previously identified in the 2023 Form 10-K Full Year 2025 Outlook4 Adjusted EBITDA between $825 million and $975 million Capital expenditures between $250 million to $300 million
View narrative
US$21.07
FV
31.7% undervalued intrinsic discount
11.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
25 days ago author updated this narrative
CC logo
Chemours
WA
Analyst Price Target
Consensus Narrative from 10 Analysts

Regulatory Shifts Toward low-GWP Technology Will Increase Opteon Refrigerants Demand

Key Takeaways Pathway to Thrive and TT plans enhance efficiency and cost savings, potentially boosting net margins and earnings growth. Opteon and Teflon expansions align with regulatory shifts and high-growth markets, potentially increasing revenues.
View narrative
US$22.20
FV
35.1% undervalued intrinsic discount
3.78%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
5 days ago author updated this narrative
View Chemours Community

The Chemours Company Competitors

Quaker Chemical

NYSE:KWR

US$2.3b

Minerals Technologies

NYSE:MTX

US$2.2b

Hawkins

NasdaqGS:HWKN

US$2.3b

Innospec

NasdaqGS:IOSP

US$2.4b

Price History & Performance

Summary of share price highs, lows and changes for Chemours
Historical stock prices
Current Share PriceUS$14.40
52 Week HighUS$29.21
52 Week LowUS$13.09
Beta1.98
1 Month Change-14.44%
3 Month Change-23.24%
1 Year Change-46.94%
3 Year Change-52.14%
5 Year Change57.72%
Change since IPO-28.11%

Recent News & Updates

It's Down 27% But The Chemours Company (NYSE:CC) Could Be Riskier Than It Looks

Mar 04
It's Down 27% But The Chemours Company (NYSE:CC) Could Be Riskier Than It Looks

Recent updates

It's Down 27% But The Chemours Company (NYSE:CC) Could Be Riskier Than It Looks

Mar 04
It's Down 27% But The Chemours Company (NYSE:CC) Could Be Riskier Than It Looks

Chemours (NYSE:CC) Seems To Be Using A Lot Of Debt

Jan 24
Chemours (NYSE:CC) Seems To Be Using A Lot Of Debt

Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?

Jan 08
Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?

Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet

Dec 05
Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet

Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright

Nov 21

Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye

Nov 12
Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye

Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?

Sep 25
Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?

Chemours: We're Back Down To Trough And A 'BUY'

Sep 01

Chemours: Upside After Irregularities, Good 2024-2026E

Jun 11

The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement

May 30
The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement

Drama At The Chemours Company Opens The Door For Upside

Mar 29

The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Mar 01
The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Chemours: The Case Amidst Board Trouble, I Say Buy The Weakness

Feb 29

Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Feb 17
Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Chemours: Technological Innovation Presents Excellent Opportunities For Growth

Dec 23

Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

Oct 30
Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Oct 28
The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Chemours: Volatile Bottom Line Needs Consistency

Oct 06

The Chemours Company: Portfolio Optimization Resulting In Compounding Growth

Sep 19

Shareholder Returns

CCUS ChemicalsUS Market
7D2.0%-3.6%-2.2%
1Y-46.9%-6.7%9.5%

Return vs Industry: CC underperformed the US Chemicals industry which returned -6.7% over the past year.

Return vs Market: CC underperformed the US Market which returned 9.5% over the past year.

Price Volatility

Is CC's price volatile compared to industry and market?
CC volatility
CC Average Weekly Movement7.0%
Chemicals Industry Average Movement5.4%
Market Average Movement6.4%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market3.4%

Stable Share Price: CC has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20146,000Denise M. Dignamwww.chemours.com

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names.

The Chemours Company Fundamentals Summary

How do Chemours's earnings and revenue compare to its market cap?
CC fundamental statistics
Market capUS$2.15b
Earnings (TTM)US$86.00m
Revenue (TTM)US$5.78b

25.0x

P/E Ratio

0.4x

P/S Ratio

Is CC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CC income statement (TTM)
RevenueUS$5.78b
Cost of RevenueUS$4.63b
Gross ProfitUS$1.15b
Other ExpensesUS$1.07b
EarningsUS$86.00m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.58
Gross Margin19.91%
Net Profit Margin1.49%
Debt/Equity Ratio671.4%

How did CC perform over the long term?

See historical performance and comparison

Dividends

6.9%

Current Dividend Yield

174%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/16 01:35
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Chemours Company is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAlembic Global Advisors
David ColemanArgus Research Company
Ishan MajumdarBaptista Research